Experience

Davis Polk represented PENTAX Medical, a global medical device manufacturer that is a division of HOYA Group, in a criminal investigation into potential misbranding of its endoscope devices…

Davis Polk advised FedEx Corporation on its SEC-registered offering of $1 billion principal amount of 3.800% notes due 2025, $750 million principal amount of 4.250% notes due 2030 and $1.25…

We advised an ad hoc group of term lenders in connection with the comprehensive recapitalization

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Equinor ASA of $1.25 billion aggregate principal amount of 2.875% fixed-rate notes…

Davis Polk advised the sole book-running manager in connection with the SEC-registered offering by Nevro Corp. of $189.75 million aggregate principal amount of its 2.75% convertible…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by South Jersey Industries, Inc. of shares of its common stock for up to an aggregate…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by General Mills, Inc., consisting of $750 million of its 2.875% notes…

Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $1.0 billion aggregate principal amount of 4.125% senior notes due 2030, fully and unconditionally guaranteed by…

Davis Polk advised Tencent in connection with its participation in a private placement by Pinduoduo Inc. to certain long-term investors of a total of $1.1 billion of newly issued Class A…

We are advising Digicel in connection with the exchange offers and consent solicitations